SinglePoint (OTC: $SING) Continues Accelerated Growth in Cannabis Sector with Letter of Intent to Acquire Dr. FeelGood

SinglePoint (OTC: $SING) Continues Accelerated Growth in Cannabis Sector with Letter of Intent to Acquire Dr. FeelGood

SEATTLE, WA - August 22, 2017 (Investorideas.com Newswire) SinglePoint, Inc. (OTC:SING) today announces it has signed a Letter of Intent (LOI) to acquire Dr. FeelGood, an already profitable Phoenix-based medical marijuana distribution company with plans to develop a proprietary delivery and ordering technology. Per the LOI, SinglePoint will acquire 51% of the company in a combination of cash and stock. The acquisition will add an additional revenue stream to SinglePoint, solidifying the company's acquisition-based revenue strategy.

SinglePoint anticipates it will quickly close this acquisition, demonstrating its ability to grow its portfolio of investments in established high-growth, high-potential cannabis businesses. SinglePoint successfully acquired two companies earlier this year, and expects that the acquisition of Dr. FeelGood will be a highly successfully addition to its portfolio.

Read this news in full at

http://www.investorideas.com/CO/SING/news/2017/08221Growth.asp

About the Company

SinglePoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base. Through its subsidiary company SingleSeed the company is providing products and services to the cannabis industry.

Disclosure: SinglePoint, Inc. (OTC: $SING) is featured on the 420 Cannabis Investor Ideas of 2017 at www.420cannabisinvestorideas.com

SinglePoint, Inc. (OTC: SING) is a featured company on Investorideas.com
View the profile on Investorideas.com

Disclaimer: This directory is not a recommendation to buy or sell securities or products or services Investorideas.com charges a fee for placement. The directory is not an endorsement or recommendation but meant to be an investor resource/ due diligence tool.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory and SING is also a paid featured cannabis and bitcoin company for news and PR social media

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Medical Cannabis Innovator Set to Go Public

Medical Cannabis Innovator Set to Go Public

Source: Streetwise Reports

August 21, 2017 (Investorideas.com Newswire) A licensed producer of medical cannabis in Canada will begin trading on the Canadian Securities Exchange on Aug. 21.

Shares of CannTrust Holdings Inc. (TRST:CSE), which has a 40,000 square foot hydroponic production facility in Vaughan, Ontario, will begin trading on the Canadian Securities Exchange on Monday, Aug. 21 under the symbol TRST.

Read this news in full at http://www.investorideas.com/news/2017/marijuana/08211MedicalCannabis.asp

Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Watch the 420 Cannabis Investor video

https://www.youtube.com/watch?v=e2zFezO580Y&t=54s

 

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

V2 Launches Prohibited Cannabis Vaporizer Brand and Product Line

V2 Launches Prohibited Cannabis Vaporizer Brand and Product Line

First Device in Product Line, 5th Degree, Now Available Online and in Select Retail Locations

NEW YORK - August 21, 2017 (Investorideas.com Newswire) Prohibited - the all new cannabis vape brand by leading independent e-cig and manufacturer, V2 - today, announced the launch of the 5th Degree vaporizer, now available for customers nationwide online and on shelves in 125 retailers in 18 states across the country. The 5th Degree is a 3-in-1 device designed and optimized for marijuana consumption.

The 5th Degree features variable voltage and temperature settings, a powerful battery and pass-thru charging. The vaporizer also comes with two magnetic drop-in cartridges; one for buds and one for concentrates or e-liquid. 5thDegree will automatically recognize each type of cartridge and perform accordingly.

Read this news in full at http://www.investorideas.com/news/2017/marijuana/08212V2.asp

Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Watch the 420 Cannabis Investor video

https://www.youtube.com/watch?v=e2zFezO580Y&t=54s

 

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

#Cannabis Stock News: iAnthus (CSE: IAN) (OTCQB: $ITHUF) Announces Update to Proposed Acquisition of Citiva

#Cannabis Stock News: iAnthus (CSE: IAN) (OTCQB: $ITHUF) Announces Update to Proposed Acquisition of Citiva

NEW YORK, NY and TORONTO, ON - August 21, 2017 (Investorideas.com Newswire) iAnthus Capital Holdings, Inc. ("iAnthus" or "the Company"), (CSE: IAN) (OTCQB: ITHUF), which owns, operates, and partners with licensed cannabis operations throughout the United States, announces that it has advanced US$500,000 to Citiva Medical, LLC ("Citiva NY") pursuant to a secured promissory note (the "Promissory Note"). The Promissory Note has a term of one year, subject to acceleration in certain events, and yields interest at a rate of up to 20%.

Read this news in full at http://www.investorideas.com/news/2017/marijuana/08213iAnthus.asp

Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Watch the 420 Cannabis Investor video

https://www.youtube.com/watch?v=e2zFezO580Y&t=54s

 

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

This Week’s Marijuana and Cannabis Stocks Added; $APP.C, $HS.C & $PTX.C

This Week’s Marijuana and Cannabis Stocks Added; $APP.C, $HS.C & $PTX.C

Point Roberts, WA, Delta BC – August 18, 2017 – Investorideas.com, a global news source and investor resource covering actively traded sectors announces this week’s additions to its cannabis /hemp stock directory for investors following the sector.

New companies are all CSE listed and include a mobile app company with a family of apps dedicated to all things cannabis, a tech company specializing in regulatory requirements and a company that is developing an online platform for the cannabis industry.

Read this news in full at

http://www.investorideas.com/news/2017/marijuana/08181Stocks.asp

The complete marijuana/hemp stock list available for purchase in a PDF format:

http://www.investorideas.com/dirs/stocklist.asp

Investorideas.com tracks companies in high profile trading sectors and makes ongoing additions to its stock directories for each sector.  Listing for the stock directories include companies on the TSX, OTC, NYSE, NASDAQ and global stock exchanges.

Investorideas.com global stock directories are part of the membership program on the site, accessed either by login and password or available in PDF format.  The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Ideas

Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.

Investorideas.com cannabis/marijuana and hemp content now includes:http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the AI site Global Cannabis Investing at www.Globalcannabisinvesting.com

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas

Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Services for Publicly traded and private companies:http://www.investorideas.com/Investors/Services.asp

Investorideas is Listed on The Canadian Securities Exchange (CSE) Directory of Service Providers

http://thecse.com/en/services/services-for-listed-companies

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution,social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info:http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com

800-665-0411

Marijuana / Hemp Stocks

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

Video News; Scythian Biosciences (TSX.V: $SCYB.V) Discusses #Cannabinoid-based Treatment for #Concussion and Traumatic Brain Injury

Video News; Scythian Biosciences (TSX.V: $SCYB.V) Discusses #Cannabinoid-based Treatment for #Concussion and Traumatic Brain Injury

August 18, 2017 – Investorideas.com, a global news source and investor resource covering cannabis and biotech stocks releases a video/ interview featuring David Schrader, Chief Operating Officer of Scythian Biosciences (TSX.V: SCYB), a company developing a drug regimen for concussion and traumatic brain injury using a cannabinoid-based combination drug therapy.

Watch video: https://www.youtube.com/watch?v=DaNLaGh0G-w

Read this news in full athttp://www.investorideas.com/CO/SCYB/news/2017/08181Video.asp

Scythian ( http://scythianbio.com/) is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination. 

Scythian's mission is to be the first accepted drug regimen for concussive treatment. Scythian has recently formed a collaboration with the University of Miami and its world renowned neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen.  The University of Miami believes that Scythian's scientific approach shows significant promise and differs from previous approaches to treat this growing problem.  The collaboration with the University of Miami allows access to their extensive knowledge base in the fields of traumatic brain injury and concussions and allows for Scythian's clinical studies to be undertaken at their world-class facilities.   

Gillian A. Hotz, PhD, is leading Scythian's program at the University of Miami.  Dr. Hotz is a nationally recognized behavioral neuroscientist and expert in neurotrauma, concussion management, and neurorehabilitation.  She has extensive experience in neurocognitive testing.  Dr. Hotz has been the co-director of University of Miami Miller School of Medicine's Concussion Program since 1995. 

Scythian is also endorsed by Pro Football Legends and the World Boxing Association on its mission.

About Investorideas.com - News that Inspires Big Ideas

www.Investorideas.com  is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.

Listen to original podcast:http://www.investorideas.com/CO/SCYB/news/2017/08161COOTalks.asp

The Investorideas.com podcasts are also available on iTunes, Tunein, Sticher. Spreaker.com, iHeart.com  and Google Play Music.

Visit the Podcast page at Investorideas.com: http://www.investorideas.com/Audio/

Subscribe to Investorideas.com Podcast RSS:

http://www.investorideas.com/rss/feeds/Podcasts.xml

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details -http://www.investorideas.com/About/News/Clientspecifics.asp

Visit Scythian Biosciences (TSX.V: SCYB  )Profile page:http://www.investorideas.com/CO/SCYB/

Contact Investorideas.com

800-665-0411

Scythian Biosciences Corp. (TSXV: $SCYB.V) Retains Hybrid Financial Ltd. for Investor Relations Activities

Scythian Biosciences Corp. (TSXV: $SCYB.V) Retains Hybrid Financial Ltd. for Investor Relations Activities

TORONTO - August 17, 2017 (Investorideas.com Newswire) Scythian Biosciences Corp. (the "Company") (TSXV: SCYB) announces that it has retained the services of Hybrid Financial Ltd. ("Hybrid Financial") for strategic investor relations activities. The initiatives includes marketing and investor relations services for the Company.

Read this news in full at

http://www.investorideas.com/CO/SCYB/news/2017/08171InvestorRelations.asp

About Scythian Biosciences Corp.

Scythian is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination.

Scythian's mission is to be the first accepted drug regimen for concussive treatment. Scythian has recently formed a collaboration with the University of Miami and its world renowned neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen. The University of Miami believes that Scythian's scientific approach shows significant promise and differs from previous approaches to treat this growing problem. The collaboration with the University of Miami allows access to their extensive knowledge base in the fields of traumatic brain injury and concussions and allows for Scythian's clinical studies to be undertaken at their world-class facilities.

Gillian A. Hotz, PhD, is leading Scythian's program at the University of Miami. Dr. Hotz is a nationally recognized behavioral neuroscientist and expert in neurotrauma, concussion management, and neurorehabilitation. She has extensive experience in neurocognitive testing. Dr. Hotz has been the co-director of University of Miami Miller School of Medicine's Concussion Program since 1995.

Scythian is also endorsed by Pro Football Legends and the World Boxing Association on its mission.

Scythian Biosciences Corp. (TSX.V: SCYB)

is a Featured biotech and marijuana company on Investorideas.com

Visit Profile page: http://www.investorideas.com/CO/SCYB/

Get News Alerts on Scythian Biosciences Corp.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.